Remdesivir has ‘little or no effect’ on Covid hospital patient mortality: WHO

Remdesivir has “little or no effect” on a hospitalised Covid-19 patients’ chances of survival, according to the WHO (Zsolt Czegledi/MTI/AP)

Antiviral drug remdesivir has “little or no effect” on a hospitalised Covid-19 patients’ chances of survival, a World Health Organisation (WHO) clinical trial has suggested.

The potential coronavirus treatment option is one of four repurposed drugs being examined under the UN agency’s large Solidarity trial that launched in March.